Literature DB >> 15031638

Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology.

Paul Ashwood1, Andrew Anthony, Alicia A Pellicer, Franco Torrente, John A Walker-Smith, Andrew J Wakefield.   

Abstract

Inflammatory intestinal pathology has been reported in children with regressive autism (affected children). Detailed analysis of intestinal biopsies in these children indicates a novel lymphocytic enterocolitis with autoimmune features; however, links with cognitive function remain unclear. To characterize further, the nature and extent of this disease we examined the mucosal infiltrate using flow cytometry. Duodenal, ileal, and colonic biopsies were obtained from 52 affected children, 25 histologically normal, and 54 histologically inflamed, developmentally normal controls. Epithelial and lamina propria lymphocyte populations were isolated and examined by multicolor flow cytometry. Adjacent biopsies were assessed by semiquantitative histopathology. At all sites, CD3(+) and CD3(+)CD8(+) IEL as well as CD3(+) LPL were significantly increased in affected children compared with developmentally normal noninflamed control groups (p<0.01) reaching levels similar to inflamed controls. In addition, two populations--CD3(+)CD4(+) IEL and LP CD19(+) B cells--were significantly increased in affected children compared with both noninflamed and inflamed control groups including IBD, at all sites examined (p<0.01). Histologically there was a prominent mucosal eosinophil infiltrate in affected children that was significantly lower in those on a gluten- and casein-free diet, although lymphocyte populations were not influenced by diet. The data provide further evidence of a pan-enteric mucosal immunopathology in children with regressive autism that is apparently distinct from other inflammatory bowel diseases.

Entities:  

Mesh:

Year:  2003        PMID: 15031638     DOI: 10.1023/b:joci.0000010427.05143.bb

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  26 in total

1.  Cow's milk and chronic constipation in children.

Authors:  N Shah; K Lindley; P Milla
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

2.  Collagenase and Dispase enzymes disrupt lymphocyte surface molecules.

Authors:  M Abuzakouk; C Feighery; C O'Farrelly
Journal:  J Immunol Methods       Date:  1996-08-14       Impact factor: 2.303

Review 3.  Immunogenetic studies in autism and related disorders.

Authors:  R P Warren; V K Singh; R E Averett; J D Odell; A Maciulis; R A Burger; W W Daniels; W L Warren
Journal:  Mol Chem Neuropathol       Date:  1996 May-Aug

4.  Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism.

Authors:  A M Comi; A W Zimmerman; V H Frye; P A Law; J N Peeden
Journal:  J Child Neurol       Date:  1999-06       Impact factor: 1.987

5.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation.

Authors:  J Bertrand; A Mars; C Boyle; F Bove; M Yeargin-Allsopp; P Decoufle
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

Review 6.  Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands.

Authors:  A J Wakefield; J M Puleston; S M Montgomery; A Anthony; J J O'Leary; S H Murch
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

7.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

Authors:  Brent Taylor; Elizabeth Miller; Raghu Lingam; Nick Andrews; Andrea Simmons; Julia Stowe
Journal:  BMJ       Date:  2002-02-16

8.  Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism.

Authors:  S Gupta; S Aggarwal; B Rashanravan; T Lee
Journal:  J Neuroimmunol       Date:  1998-05-01       Impact factor: 3.478

Review 9.  Autism and Clostridium tetani.

Authors:  E R Bolte
Journal:  Med Hypotheses       Date:  1998-08       Impact factor: 1.538

Review 10.  Early identification of autism by the CHecklist for Autism in Toddlers (CHAT).

Authors:  S Baron-Cohen; S Wheelwright; A Cox; G Baird; T Charman; J Swettenham; A Drew; P Doehring
Journal:  J R Soc Med       Date:  2000-10       Impact factor: 5.344

View more
  55 in total

Review 1.  Microbe hunting.

Authors:  W Ian Lipkin
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 2.  Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families.

Authors:  R Scott Akins; Kathy Angkustsiri; Robin L Hansen
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 3.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 4.  The power and promise of identifying autism early: insights from the search for clinical and biological markers.

Authors:  Karen Pierce; Stephen J Glatt; Gregory S Liptak; Laura Lee McIntyre
Journal:  Ann Clin Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.567

5.  Eosinophilic esophagitis as a cause of feeding problems in autistic boy. The first reported case.

Authors:  Elżbieta Jarocka-Cyrta; Jolanta Wasilewska; Maciej Gustaw Kaczmarski
Journal:  J Autism Dev Disord       Date:  2011-03

6.  Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders.

Authors:  Bryan Jepson; Doreen Granpeesheh; Jonathan Tarbox; Melissa L Olive; Carol Stott; Scott Braud; J Helen Yoo; Andrew Wakefield; Michael S Allen
Journal:  J Autism Dev Disord       Date:  2011-05

Review 7.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

8.  A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.

Authors:  Benjamin L Handen; Raun D Melmed; Robin L Hansen; Michael G Aman; David L Burnham; Jon B Bruss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-01-16

9.  Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease.

Authors:  A J Russo; A Krigsman; B Jepson; Andrew Wakefield
Journal:  Biomark Insights       Date:  2009-11-27

10.  Altered gene expression and function of peripheral blood natural killer cells in children with autism.

Authors:  Amanda M Enstrom; Lisa Lit; Charity E Onore; Jeff P Gregg; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto; Judy A Van de Water; Frank R Sharp; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2008-08-14       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.